BIPHOZYL

This brand name is authorized in Austria, Brazil, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Lithuania, Malta, Poland, Romania, Singapore, Spain, Turkey.

Active ingredients

The drug BIPHOZYL contains a combination of these active pharmaceutical ingredients (APIs):

1	Magnesium chloride hexahydrate UNII 02F3473H9O - MAGNESIUM CHLORIDE
	Read more about Magnesium chloride
2	Sodium chloride UNII 451W47IQ8X - SODIUM CHLORIDE
	Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue.
	Read more about Sodium chloride
3	Sodium hydrogen carbonate UNII 8MDF5V39QO - SODIUM BICARBONATE
	Sodium bicarbonate has antacid properties. Sodium bicarbonate causes neutralisation of gastric acid with the production of carbon dioxide.
	Read more about Sodium bicarbonate
4	Potassium chloride UNII 660YQ98I10 - POTASSIUM CHLORIDE
	Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism.
	Read more about Potassium chloride
5	Disodium phosphate dihydrate UNII 94255I6E2T - SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
	Read more about Sodium phosphate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BIPHOZYL Solution for haemodialysis	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B05ZB	Hemofiltrates	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05Z Hemodialytics and hemofiltrates
Discover more medicines within B05ZB

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	503220110030807
EE	Ravimiamet	1625891
ES	Centro de información online de medicamentos de la AEMPS	79998
FI	Lääkealan turvallisuus- ja kehittämiskeskus	039918
FR	Base de données publique des médicaments	65428529
HK	Department of Health Drug Office	65328
HR	Agencija za lijekove i medicinske proizvode	HR-H-197145098
LT	Valstybinė vaistų kontrolės tarnyba	1071196
MT	Medicines Authority	MA1277/03201
PL	Rejestru Produktów Leczniczych	100329553
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67896001, W67896002
SG	Health Sciences Authority	15514P
TR	İlaç ve Tıbbi Cihaz Kurumu	8681413881459, 8681413881480